Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00522912
Other study ID # 5024
Secondary ID
Status Completed
Phase N/A
First received August 28, 2007
Last updated January 11, 2012
Start date March 2008
Est. completion date May 2010

Study information

Verified date January 2012
Source London School of Hygiene and Tropical Medicine
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics CommitteeEthiopia: Ethiopia Science and Technology CommissionUnited States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Trachoma is the leading infectious cause of blindness worldwide. Recurrent infection by Chlamydia trachomatis causes a gradual scarring process of the inner surface of the eyelid (conjunctiva) leading to in-turning of the eyelids (entropion) and lashes touching the eye (trichiasis). The rate of progression and the severity of disease are variable. Some people develop severe disease with extensive entropion and trichiasis, whilst others have a mild problem with only a few lashes touching the eye, which does not progress.

In more advanced cases there is a broad consensus that the entropion / trichiasis should be corrected by surgery. In mild cases (minor trichiasis: 1-5 lashes touching the eye) the optimal treatment is uncertain. Some advocate early surgery to turn the eyelid out for any individual with one or more lashes touching any part of the eye. Others consider this to be too early for surgical intervention, as surgery can have a high recurrence rate and complications can arise. Instead, they recommend that minor trichiasis can be managed by epilation (pulling out lashes with forceps). In many endemic regions the uptake of surgery is low, with many patients preferring to epilate for mild disease.

The primary purpose of this study is to compare the outcome of immediate surgery to regular epilation for the management of minor trichiasis. The epilation would be done by a person with good eyesight using proper epilation forceps.


Recruitment information / eligibility

Status Completed
Enrollment 1300
Est. completion date May 2010
Est. primary completion date May 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Minor trichiasis: 1 - 5 lashes touching the eye

Exclusion Criteria:

- Previous eyelid surgery.

- Patients with evidence of corneal damage (will be offered surgery).

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Trichiasis surgery
Posterior lamella tarsal rotation
Epilation
Epilation of lashes by another well sighted person using quality epilating forceps

Locations

Country Name City State
Ethiopia Bahir Dar Regional Health Bureau Bahir Dar Amhara

Sponsors (1)

Lead Sponsor Collaborator
London School of Hygiene and Tropical Medicine

Country where clinical trial is conducted

Ethiopia, 

References & Publications (1)

Rajak SN, Habtamu E, Weiss HA, Kello AB, Gebre T, Genet A, Bailey RL, Mabey DC, Khaw PT, Gilbert CE, Emerson PM, Burton MJ. Surgery versus epilation for the treatment of minor trichiasis in Ethiopia: a randomised controlled noninferiority trial. PLoS Med. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Trichiasis One and two years No
Secondary Visual acuity One and two years No
Secondary Corneal opacity One and two years No
See also
  Status Clinical Trial Phase
Completed NCT00522860 - A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis Surgery Phase 4

External Links